Core Viewpoint - Allstate has recently gained attention as one of the most searched stocks, with a notable performance compared to the broader market and its industry [1][2]. Earnings Estimate Revisions - For the current quarter, Allstate is expected to report earnings of $3.98 per share, reflecting a decrease of -22.4% year-over-year, with a consensus estimate change of -3.8% over the last 30 days [5]. - The consensus earnings estimate for the current fiscal year is $18.62, indicating a slight increase of +1.6% from the previous year, with a minor change of -0.2% in the last month [5]. - For the next fiscal year, the earnings estimate is $21.64, suggesting a growth of +16.2% year-over-year, with an increase of +1.8% in the past month [6]. Revenue Growth Forecast - The consensus sales estimate for the current quarter is $17.13 billion, representing a year-over-year increase of +11% [9]. - For the current fiscal year, the revenue estimates are $69.64 billion and $74.95 billion for the next fiscal year, indicating changes of +8.3% and +7.6%, respectively [9]. Last Reported Results and Surprise History - In the last reported quarter, Allstate achieved revenues of $16.71 billion, a year-over-year increase of +12.1%, with an EPS of $7.67 compared to $5.82 a year ago [10]. - The reported revenues were in line with the Zacks Consensus Estimate, showing a surprise of -0.01%, while the EPS surprise was +17.82% [11]. - Allstate has consistently beaten consensus EPS estimates in the last four quarters and topped revenue estimates three times during this period [11]. Valuation - Allstate is graded A in the Zacks Value Style Score, indicating it is trading at a discount compared to its peers [15]. - The evaluation of valuation multiples such as P/E, P/S, and P/CF is essential to determine if the stock is fairly valued, overvalued, or undervalued [13][14]. Conclusion - The current Zacks Rank of 3 suggests that Allstate may perform in line with the broader market in the near term, despite the market buzz surrounding the stock [16].

Core Viewpoint - Adma Biologics has shown strong stock performance recently, significantly outperforming the broader market and its industry, raising questions about its future trajectory [2][16]. Earnings Estimate Revisions - For the current quarter, Adma Biologics is expected to report earnings of $0.16 per share, reflecting a 100% increase year-over-year, with a 6.7% upward revision in estimates over the last 30 days [5]. - The consensus earnings estimate for the current fiscal year is $0.71, indicating a 44.9% year-over-year increase, with a 3.7% upward revision in the last month [5]. - For the next fiscal year, the consensus estimate is $0.93, representing a 31% increase from the previous year, with a 6.9% upward revision [6]. - The Zacks Rank for Adma Biologics is 2 (Buy), indicating a positive outlook based on recent earnings estimate revisions [7]. Revenue Growth Forecast - The consensus sales estimate for the current quarter is $119.1 million, showing a year-over-year increase of 45.5% [9]. - For the current fiscal year, the sales estimate is $495.8 million, indicating a 16.3% increase, while the next fiscal year's estimate is $611.5 million, reflecting a 23.3% increase [9]. Last Reported Results and Surprise History - In the last reported quarter, Adma Biologics achieved revenues of $117.55 million, a 59.1% year-over-year increase, and an EPS of $0.14 compared to $0.04 a year ago [11]. - The company exceeded consensus revenue estimates in all four of the last quarters and surpassed EPS estimates three times [11]. Valuation - Adma Biologics has a Zacks Value Style Score of D, indicating it is trading at a premium compared to its peers [15].

Core Viewpoint - Boston Scientific (BSX) has been a highly searched stock recently, indicating potential investor interest and market activity [1] Earnings Estimates Revisions - For the current quarter, Boston Scientific is expected to report earnings of $0.67 per share, reflecting a year-over-year increase of +19.6% [5] - The Zacks Consensus Estimate for the current fiscal year is $2.85, indicating a +13.6% change from the previous year, with a +2.7% increase in estimates over the last 30 days [5] - For the next fiscal year, the consensus estimate is $3.23, showing a +13.2% change from the prior year, with a +2.2% increase in estimates over the past month [6] - The Zacks Rank for Boston Scientific is 2 (Buy), suggesting a positive outlook based on recent earnings estimate revisions [7] Revenue Growth Forecast - The consensus sales estimate for the current quarter is $4.56 billion, indicating a year-over-year increase of +18.2% [9] - For the current fiscal year, the sales estimate is $19.05 billion, reflecting a +13.8% change, while the next fiscal year's estimate is $21 billion, indicating a +10.2% change [9] Last Reported Results and Surprise History - Boston Scientific reported revenues of $4.56 billion in the last quarter, representing a +22.4% year-over-year change [10] - The reported EPS was $0.70, compared to $0.55 a year ago, with a revenue surprise of +3.52% and an EPS surprise of +7.69% [11] - The company has consistently beaten consensus EPS and revenue estimates over the last four quarters [11] Valuation - Boston Scientific has a Zacks Value Style Score of D, indicating it is trading at a premium compared to its peers [15]

Core Viewpoint - Allstate's stock has shown a positive return of +3.4% over the past month, contrasting with the S&P 500's decline of -4.1%, indicating potential resilience in its performance [1] Earnings Estimate Revisions - For the current quarter, Allstate is expected to report earnings of $4 per share, reflecting a decrease of -22% year-over-year, with the consensus estimate dropping by -23.6% in the last 30 days [4] - The consensus earnings estimate for the current fiscal year is $18.65, indicating a slight increase of +1.8% from the previous year, with a minor change of -0.6% over the last month [4] - For the next fiscal year, the consensus estimate is $21.61, suggesting a growth of +15.9% compared to the previous year, with a recent increase of +4.1% [5] Revenue Growth Forecast - The consensus sales estimate for the current quarter is $17.13 billion, representing a year-over-year increase of +11% [8] - For the current fiscal year, the revenue estimate is $69.64 billion, indicating a growth of +8.3%, while the next fiscal year's estimate is $74.95 billion, reflecting a +7.6% change [8] Last Reported Results and Surprise History - In the last reported quarter, Allstate achieved revenues of $16.71 billion, marking a year-over-year increase of +12.1%, with an EPS of $7.67 compared to $5.82 a year ago [9] - The reported revenues were in line with the Zacks Consensus Estimate, showing a surprise of -0.01%, while the EPS surprise was +17.82% [10] - Allstate has consistently beaten consensus EPS estimates in the last four quarters and has topped revenue estimates three times during this period [10] Valuation - Allstate is graded A in the Zacks Value Style Score, indicating that it is trading at a discount compared to its peers [14]

Core Viewpoint - Agnico Eagle Mines (AEM) has shown a positive stock performance of +1% over the past month, contrasting with the Zacks S&P 500 composite's -4.1% change, indicating potential resilience in the gold mining sector [1] Earnings Estimates Revisions - Agnico is expected to report earnings of $1.05 per share for the current quarter, reflecting a year-over-year increase of +38.2%, with a recent consensus estimate change of +9.2% [4] - For the current fiscal year, the consensus earnings estimate stands at $4.70, indicating a year-over-year change of +11.1%, although this estimate has decreased by -1.2% over the last 30 days [4] - The next fiscal year's consensus earnings estimate is $4.13, suggesting a decline of -12.1% from the previous year, with a slight increase of +0.5% in the last month [5] Revenue Growth Forecast - The consensus sales estimate for Agnico is $2.24 billion for the current quarter, representing a year-over-year growth of +22.4% [8] - For the current fiscal year, revenue estimates are $9.22 billion, indicating a growth of +11.3%, while the next fiscal year's estimate of $8.9 billion reflects a decline of -3.5% [8] Last Reported Results and Surprise History - In the last reported quarter, Agnico achieved revenues of $2.22 billion, marking a year-over-year increase of +26.6%, with an EPS of $1.26 compared to $0.57 a year ago [9] - The reported revenues exceeded the Zacks Consensus Estimate of $2.1 billion by +6.03%, and the EPS surprise was +7.69% [10] - Agnico has consistently beaten consensus EPS and revenue estimates in the last four quarters [10] Valuation - Agnico holds a Zacks Rank 3 (Hold), indicating it may perform in line with the broader market in the near term [6][15] - The Zacks Value Style Score grades Agnico as C, suggesting it is trading at par with its peers [14]

Core Viewpoint - Airbnb's stock has shown a strong performance recently, returning +10% over the past month, contrasting with the S&P 500's -4.1% and the Leisure and Recreation Services industry's -6% [1] Earnings Estimates Revisions - For the current quarter, Airbnb is expected to report earnings of $0.26 per share, reflecting a decrease of -36.6% year-over-year, with a +9.7% increase in the Zacks Consensus Estimate over the last 30 days [4] - The consensus earnings estimate for the current fiscal year is $4.31, indicating a year-over-year increase of +4.9%, with a slight change of +0.4% in the last 30 days [4] - For the next fiscal year, the consensus estimate is $4.98, representing a +15.5% increase from the previous year, with a +1.2% change over the past month [5] Revenue Growth Forecast - The consensus sales estimate for the current quarter is $2.27 billion, indicating a year-over-year growth of +6% [8] - For the current fiscal year, the revenue estimates are $12.22 billion and $13.54 billion, reflecting changes of +10.1% and +10.8%, respectively [8] Last Reported Results and Surprise History - In the last reported quarter, Airbnb generated revenues of $2.48 billion, marking an +11.8% year-over-year increase, with an EPS of $0.73 compared to $0.76 a year ago [9] - The reported revenues exceeded the Zacks Consensus Estimate of $2.42 billion by +2.47%, and the EPS surprise was +25.86% [10] - Over the last four quarters, Airbnb surpassed consensus EPS estimates twice and revenue estimates three times [10] Valuation - Airbnb is graded D in the Zacks Value Style Score, indicating it is trading at a premium compared to its peers [14]